Cancer Research UK CTU gets £4.5mn for pancreatic cancer research
Date: 2018-02-15   Author: Saipriya Iyer  Category: #news

Cancer Research UK CTU gets £4.5mn for pancreatic cancer research

The Cancer Research UK, a charitable organization in the UK focusing on cancer research & healthcare, has offered funds worth £4.5 million for the Cancer Research UK Clinical Trials Unit (CTU) in Scotland after assessing a review report of all its clinical trial units. Sources state that the Cancer Research UK CTU in Scotland was one of the eight sites to receive funds from the Cancer Research UK.

For the record, the UK based charitable institution has already allotted funds worth £10 million for Cancer Research UK Clinical Trials Unit to conduct a study that will help in differentiating between pancreatic cancer patients based on the molecular makeup of their cancer lumps during the three clinical tests. One of the researchers working at the firm has stated that subjects diagnosed with pancreatic cancer send their tumor cells to the CTU lab for genetic testing. He further claimed that based on the test results, the patient is advised to undergo clinical tests that suits a particular disease type, thereby helping the physicians to offer better treatment to the patient and prevent side effects.

According to BBC News, scientists at the Glasgow University based center have been carrying out extensive research since long to unearth new ways of treating patients with lung cancer, pancreatic cancer, brain tumors, and prostate cancers to improve the rate of patient survival.

Reportedly, around 32,000 persons in Scotland are diagnosed with some form of cancer on an annual basis, with rising cancer cases witnessed among women. The overall survival rate in cancer patients has increased in the country over the last four decades and today, nearly half of the patients survive the disease for nearly 10 years. Experts claim that the research carried out in the institutions such as Cancer Research UK will thus contribute toward increasing patient survival rate to at least 75% by 2034.



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

Chemical Software Market 2020 Analysis & Forecast to 2025 by Key Players, Share, Trend, Segmentation
Author: Ashwin Naphade

Market Study Report has added a new report on Chemical Software Market Analysis that elucidates an in-depth synopsis of this business vertical over the forecast period. The report is inclusive of the prominent industry drivers and provides an accu...


Chemical Peel Market Share, Growth Forecast- Global Industry Outlook
Author: Ashwin Naphade

Global Chemical Peel Market Report estimates the drivers, restraints, and opportunities pertaining to the Chemical Peel industry over the timeframe of 2019-2024. Delivering the key insights pertaining to this industry, the report provides an in-de...


Chemical Logistics Market Research Report Analysis and Forecasts to 2025
Author: Ashwin Naphade

' Chemical Logistics Market forecast report now available with Market Study Report encompasses an exhaustive study of this business space with regards to pivotal industry drivers, market share analysis, and the latest trends characterizing the...